Institutional Investors Control 52% of Astrana Health, Inc. (NASDAQ:ASTH) and Were Rewarded Last Week After Stock Increased 7.4%
Jefferies Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $62
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
Truist Financial Keeps Their Buy Rating on Astrana Health (ASTH)
Express News | Astrana Health Inc : Btig Raises Target Price to $60 From $50
Express News | Astrana Health Inc : Jefferies Raises Target Price to $62 From $51
Lake Street Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $70
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH) and REPRO-MED Systems (KRMD)
Astrana Health Announces Major Acquisitions and Earnout Agreement
Express News | Astrana Health- Apt Will Purchase All of Outstanding Equity Interests in Gtpa and Heritage Physician Networks for Purchase Price of $37.5 Million
Express News | Astrana Health- Co, Apollocare Partners of Texas 2 Entered Into a Securities Purchase Agreement
Astrana Health to Pay $37.5 Million; Deal Includes Earnouts of Up to $21.5 Million >ASTH
Astrana: Collaborative Serves More Than 129,000 Beneficiaries Across 17 States >ASTH CNC
Express News | Astrana Health: To Provide Update to Combined Entity's Financial Outlook Once Deal Closes
Express News | Astrana Health Enters Definitive Agreement to Acquire Collaborative Health Systems
Astrana Health, Inc. Schedules 2024 Second Quarter Financial Results Release and Conference Call
Astrana Health and Elation Health Announce Partnership
Express News | Astrana Health Announces Strategic Partnership With Elation Health To Launch Value-Based Care Solution In Hawai'i; Partnership Aims To Provide High-Quality, Accessible Healthcare Through Elation's EHR Platform Used By Over 32,000 Clinicians Caring For...
Express News | Astrana Health and Elation Health Form Nationwide Partnership to Expand Sustainable Support Infrastructure for Primary Care Physicians
Astrana Health, Inc.'s (NASDAQ:ASTH) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 33% Over Last Week